Accelerate sustainable growth with evidence, competitive clarity, and market-focused strategies

Once your product is launched, the next challenge is achieving scale, expanding into new geographies, strengthening reimbursement, driving clinical adoption, and staying ahead of competitors. Cetas Healthcare’s Growth & Expansion solutions help MedTech companies deepen market penetration, enter new regions, expand indications, and reinforce long-term product competitiveness.
Generate robust real-world clinical insights—capturing outcomes, safety, resource use, and workflow impact—to support adoption, reimbursement, and policy decisions.
Demonstrate economic value through cost-effectiveness models, budget impact analyses, humanistic outcomes, usability studies, and HTA-ready evidence packages. We help quantify how your product improves outcomes and reduces system-level costs.
Continuous, forward-looking intelligence to monitor competitor actions, emerging technologies, evidence pipelines, pricing moves, market shifts, and white-space opportunities. We equip product teams with visibility needed to refine strategy and maintain differentiation.
Identify high-potential markets and geographies, evaluate regulatory and reimbursement landscapes, assess customer needs, and design effective route-to-market (RTM) strategies. We provide clear recommendations to support go/no-go decisions and smooth market entry.




Cetas Healthcare is the world’s leading boutique MedTech market research firm. We blend agency-grade research with strategic intelligence frameworks to track pipelines, regulatory shifts, clinical trials, and GTM strategies. As pioneers of ISO 14155-compliant PMCF surveys, we’ve managed 25,000+ patient case forms for Class II & III devices, helping clients secure CE certifications and stay ahead of EU MDR requirements.
Contact Us: communication@cetas-healthcare.com
Visit Our Pages